Chordate Medical Holding AB (OSTO:CMH) Cash-to-Debt : No Debt ⁽¹⁾ (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Chordate Medical Holding AB's cash to debt ratio for the quarter that ended in Dec. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Chordate Medical Holding AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Chordate Medical Holding AB's Cash-to-Debt or its related term are showing as below:

OSTO:CMH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.35 Med: No Debt Max: No Debt
Current: No Debt

During the past 9 years, Chordate Medical Holding AB's highest Cash to Debt Ratio was No Debt. The lowest was 0.35. And the median was No Debt.

OSTO:CMH's Cash-to-Debt is ranked better than
99.65% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.91 vs OSTO:CMH: No Debt

Chordate Medical Holding AB Cash-to-Debt Historical Data

The historical data trend for Chordate Medical Holding AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Chordate Medical Holding AB Cash-to-Debt Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

Chordate Medical Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Chordate Medical Holding AB's Cash-to-Debt

For the Medical Devices subindustry, Chordate Medical Holding AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Cash-to-Debt falls into.

Chordate Medical Holding AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Chordate Medical Holding AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Chordate Medical Holding AB had no debt ⁽¹⁾.

Chordate Medical Holding AB's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Chordate Medical Holding AB had no debt ⁽¹⁾.

Chordate Medical Holding AB (OSTO:CMH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Chordate Medical Holding AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB (OSTO:CMH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines

Chordate Medical Holding AB (OSTO:CMH) Cash-to-Debt : No Debt (1) (As of Dec. 2023)